SC 13G/A

ARCH VENTURE FUND VIII, L.P. - DENALI THERAPEUTICS INC. -- SCH 13G/A (#3E)

Company: Denali Therapeutics Inc.
Filed: February 8, 2022
Accession Number: 0001072613-22-000061

View Document ↗ View on SEC.gov ↗